These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19673357)

  • 1. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
    Baba S; Yamanaka N; Suzuki K; Furukawa M; Furuya N; Ubukata K; Totsuka K
    Jpn J Antibiot; 2009 Apr; 62(2):155-77. PubMed ID: 19673357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].
    Kijima K; Sato N; Koresawa T; Morita J; Hayashi H; Shibasaki S; Kurosawa T; Totsuka K
    Jpn J Antibiot; 2009 Apr; 62(2):143-54. PubMed ID: 19673356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of tebipenem pivoxil (ME1211), a novel oral carbapenem antibiotic, in pediatric patients with otolaryngological infection or pneumonia.
    Sato N; Kijima K; Koresawa T; Mitomi N; Morita J; Suzuki H; Hayashi H; Shibasaki S; Kurosawa T; Totsuka K
    Drug Metab Pharmacokinet; 2008; 23(6):434-46. PubMed ID: 19122338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on yearly changes in tebipenem susceptibility of bacterial isolates from pediatric patients -A post-marketing surveillance of tebipenem pivoxil granules for pediatric.
    Sugano T; Takata T; Senju N; Takayama Y; Ida T
    Jpn J Antibiot; 2016 Aug; 69(4):265-290. PubMed ID: 30226954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
    Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
    Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
    Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K
    Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals].
    Kijima K; Morita J; Suzuki K; Aoki M; Kato K; Hayashi H; Shibasaki S; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):214-40. PubMed ID: 19882982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue and aural discharge distribution of tebipenem pivoxil].
    Baba S; Kasahara H; Morita J; Aizawa K; Sunakawa K
    Jpn J Antibiot; 2009 Apr; 62(2):127-35. PubMed ID: 19673354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
    Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good transfer of tebipenem into middle ear effusion conduces to the favorable clinical outcomes of tebipenem pivoxil in pediatric patients with acute otitis media.
    Sugita R
    J Infect Chemother; 2013 Jun; 19(3):465-71. PubMed ID: 23393013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    Sakata H
    Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
    Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K
    Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriological, pharmacokinetic and clinical studies of SY5555 dry syrup in the pediatric field].
    Toyonaga Y; Ishihara T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1995 Jan; 48(1):71-91. PubMed ID: 7699846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
    Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
    Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections.
    McEntee L; Johnson A; Farrington N; Unsworth J; Dane A; Jain A; Cotroneo N; Critchley I; Melnick D; Parr T; Ambrose PG; Das S; Hope W
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical investigation on target value of T>MIC in carbapenems].
    Mikamo H; Yamagishi Y; Tanaka K; Watanabe K
    Jpn J Antibiot; 2008 Apr; 61(2):73-81. PubMed ID: 18669417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field].
    Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Oda K; Sakata Y; Kato H; Yamashita F; Imai S
    Jpn J Antibiot; 1995 Feb; 48(2):238-60. PubMed ID: 7745814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1999)].
    Shimada K; Nakano K; Ohno I; Okada S; Hayashi K; Yokouchi H; Arakawa M; Gejyo F; Igarashi K; Ikemoto H; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Inagawa H; Ando M; Suga M; Sato K; Kudo K; Kobayashi N; Tosaka M; Hasegawa M; Kohno S; Tomono K; Miyazaki Y; Kobayashi H; Kawai S; Takayasu S; Hirakata Y; Matsuda J; Mochida C; Ito A; Sumitomo M; Nasu M; Nagai H; Matsushima T; Niki Y; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2001 Jul; 54(7):331-64. PubMed ID: 11560054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological and clinical studies of SY5555 in pediatric field].
    Nishimura T; Sugita K; Aoki S; Takagi M
    Jpn J Antibiot; 1995 Feb; 48(2):191-9. PubMed ID: 7745808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PK/PD breakpoints and clinical/bacteriological effects of cefcapene pivoxil fine granules for children at free drug concentrations in pediatric patients with respiratory infection].
    Toyonaga Y; Iwai N; Motohiro T; Sunakawa K; Fujii R
    Jpn J Antibiot; 2008 Jun; 61(3):172-83. PubMed ID: 18814800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.